|
INPP4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.044600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.093000E-01 |
| Normal-vs-Stage2 |
8.321200E-01 |
| Normal-vs-Stage3 |
3.320800E-01 |
| Normal-vs-Stage4 |
9.625000E-01 |
| Stage1-vs-Stage2 |
5.023200E-01 |
| Stage1-vs-Stage3 |
8.452800E-01 |
| Stage1-vs-Stage4 |
6.496200E-01 |
| Stage2-vs-Stage3 |
6.099000E-01 |
| Stage2-vs-Stage4 |
8.680800E-01 |
| Stage3-vs-Stage4 |
6.655200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.357400E-01 |
| Normal-vs-AfricanAmerican |
1.897990E-01 |
| Normal-vs-Asian |
2.989000E-01 |
| Caucasian-vs-AfricanAmerican |
8.160000E-01 |
| Caucasian-vs-Asian |
6.099800E-02 |
| AfricanAmerican-vs-Asian |
2.248800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.873700E-02 |
| Normal-vs-Female |
1.211970E-01 |
| Male-vs-Female |
2.139900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.370200E-01 |
| Normal-vs-Extreme_Weight |
3.349900E-02 |
| Normal-vs-Obese |
1.736620E-01 |
| Normal-vs-Extreme_Obese |
1.175890E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.392980E-01 |
| Normal_Weight-vs-Obese |
2.575200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.138100E-02 |
| Extreme_Weight-vs-Obese |
4.119600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.683630E-01 |
| Obese-vs-Extreme_Obese |
1.162420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.118200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.659600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.737600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.061600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.956990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.859180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.799870E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.863800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.794000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.252810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.620010E-03 |
| Normal-VS-Type2 PRCC |
4.642400E-01 |
| Normal-VS-KIRP CIMP |
4.044800E-03 |
| Normal-VS-Unclassified PRCC |
5.738200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.818400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.97839999999517E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.596350E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.752410E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.136400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.559220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.654200E-02 |
| Normal-vs-N1 |
2.694200E-01 |
| Normal-vs-N2 |
2.041600E-01 |
| N0-vs-N1 |
2.516400E-02 |
| N0-vs-N2 |
1.930650E-01 |
| N1-vs-N2 |
8.266000E-01 |
|
|
